Dec 27, 2023
1027:993
For every 993 shares held, investors received 1027. The price per share adjusted from $60.40 to $58.40.
The split itself did not change the total investment value.
LI KANG BIOMEDICAL Co. Ltd. (TPEX:6242) operates in the Other consumer services industry.
LI KANG BIOMEDICAL Co. Ltd. company overviewLI KANG BIOMEDICAL Co. Ltd.'s most recent stock split was on December 27, 2023. It was a 1027-for-993 forward split, so shareholders received 1027 shares for every 993 they held.
LI KANG BIOMEDICAL Co. Ltd. (TPEX:6242) has split its stock 8 times: a 21-for-20 split on August 13, 2003, a 146-for-241 reverse split on April 24, 2009, a 153-for-752 reverse split on November 10, 2011, a 49-for-183 reverse split on April 11, 2014, a 111-for-100 split on August 31, 2016, a 21-for-20 split on July 4, 2022, a 23-for-20 split on June 30, 2023, and a 1027-for-993 split on December 27, 2023.
LI KANG BIOMEDICAL Co. Ltd. has split its stock 8 times. This history records 8 splits between August 13, 2003 and December 27, 2023.
A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In LI KANG BIOMEDICAL Co. Ltd.'s 1027-for-993 split on December 27, 2023, every 993 shares became 1027 shares.
LI KANG BIOMEDICAL Co. Ltd. has not announced a new split in our records. Its most recent split was on December 27, 2023, 2 years ago. Companies announce splits in advance, and any new TPEX:6242 split will appear on this page.
Already premium?